Details of the Drug | DrugMAP

General Information of Drug (ID: DM5AALL)

Drug Name

CC-11050

Indication

Disease Entry	ICD 11	Status	REF
Cutaneous lupus erythematosus	EB5Z	Phase 2	[1]
------------------------------------------------------------------------------------

Structure

3D MOL

2D MOL

Chemical Identifiers

Formula: C24H28N2O6S
Canonical SMILES: CCOC1=C(C=CC(=C1)C(CS(=O)(=O)C)N2CC3=C(C2=O)C(=CC=C3)NC(=O)C4CC4)OC
InChI: 1S/C24H28N2O6S/c1-4-32-21-12-16(10-11-20(21)31-2)19(14-33(3,29)30)26-13-17-6-5-7-18(22(17)24(26)28)25-23(27)15-8-9-15/h5-7,10-12,15,19H,4,8-9,13-14H2,1-3H3,(H,25,27)/t19-/m1/s1
InChIKey: QDZOBXFRIVOQBR-LJQANCHMSA-N

Cross-matching ID

PubChem CID: 10322579
CAS Number: 340019-69-4
TTD ID: D0LE6F

References

1	ClinicalTrials.gov (NCT01300208) To Evaluate the Preliminary Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Efficacy of CC-11050 in Subjects With Discoid Lupus Erythematosus and Subacute Cutaneous Lupus Erythematosus. U.S. National Institutes of Health.